In order to strengthen and expand the R&D pipeline and accelerate the commercialization of products, it has always been common
for pharmaceutical companies to join forces in the industry.
It is worth mentioning that just entering December, a number of pharmaceutical companies have released cooperation news, involving the commercialization of new drugs, hand-in-hand cooperation to improve accessibility.
.
.
Luye Pharma joins hands with Enhua Pharmaceutical
On December 1, Luye Pharmaceutical, Enhua Pharmaceutical, and Good Mood signed a tripartite strategic cooperation agreement
on its recently approved antidepressant innovative drug Ruoxinlin ® (Toludi venlafaxine hydrochloride sustained-release tablets).
It is reported that Ruoxinlin ® is the first class 1 innovative drug
independently developed and has independent intellectual property rights for the treatment of depression.
According to the agreement, the three parties will actively explore in-depth cooperation in the field of mental illness, fully integrate their respective field expertise, platform advantages and commercialization resources, and actively carry out in-depth cooperation around the blockbuster variety Ruoxinlin ® approved for marketing by Luye Pharmaceutical, so as to accelerate the commercialization of this variety in China
.
Becton Medical has joined forces with NanoString
On December 1, medical technology company Becton Medical and NanoString jointly announced that they will start a strategic cooperation in the field of single-cell spatial multiomics, combining the advantages of both parties to provide one-stop technical tools and services
for domestic basic scientific research, clinical research and biomedical research and development.
This cooperation will combine the world's leading single-cell multi-omics and spatomics technologies, focus on future-oriented scientific research and clinical application scenarios, and create end-to-end full-link solutions
.
The two parties will take BD Rhapsody™ single-cell multi-omics and NanoString spatial omics products as the core overall solutions, give full play to the complementary advantages of products and technologies, and carry out comprehensive mutual trust cooperation
in market publicity and education, establishment and support of service providers, regional channel development, key customer maintenance, technical solution research and development, and emerging application field development.
CR Pharma announced two collaborations in succession
On December 1st, the signing ceremony of strategic cooperation between China Resources Pharmaceutical Business Group and the Affiliated Provincial Hospital of Shandong First Medical University was successfully held
.
Based on the consensus on the coordinated development of medicine, teaching, research and production, the two sides will jointly build a "science and technology innovation center" platform based on the frontier of medical exploration and innovation, realize online and offline chronic disease management, artificial intelligence, promote clinical and translational medical research, explore new models of drug research and development cooperation, and create a first-class highland of scientific and technological innovation, talent training and industrial development to achieve win-win
cooperation.
It is worth mentioning that on November 30, China Resources Li'an Wuxi Pharmaceutical Co.
, Ltd.
, a subsidiary of China Resources Pharmaceutical Commercial Group Co.
, Ltd.
, also signed a strategic framework agreement with Shanghai Shengzhe Medical Technology Co.
, Ltd
.
, which will deepen cooperation based on business expertise in the field of energy devices and build a situation of resource sharing and win-win cooperation.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
